Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2025 Earnings Call Transcript May 7, 2025
Avadel Pharmaceuticals plc beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.07.
Operator: Greetings, and welcome to Avadel Pharmaceuticals First Quarter 2025 Earnings Call. At this time, all participants are in a listen only mode. Accompanying slides for this call can be found on Avadel’s Investor Relations Web site. A question-and-answer session will follow the formal...
